Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression
| Image |  |
|---|---|
| Description | scientific article published on 24 October 2009 |
| Author/s |
author: Aristoteles A N Giagounidis Carlo Aul Gudrun Göhring |
| Publication date | October 24, 2009 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |